C. Abegglen, A. Joss, C. Mcardell, G. Fink, M. Schlüsener et al., The fate of 677 selected micropollutants in a single-house MBR, Water Research, vol.43, pp.2036-2046, 2009.

A. Barrios-martinez, E. Barbot, B. Marrot, P. Moulin, and N. Roche, Degradation of phenol-containing 679 effluents by MBR, J. Membrane Sci, vol.288, pp.288-296, 2006.

I. Buerge, H. Buser, T. Poiger, and M. Müller, 1st Network Conference on Persistent Organic 681 Pollutants: Human Exposure and Impacts, 2006.

L. Delgado, Bioréacteur à membrane externe pour le traitement d'effluents contenant des 683 médicaments anticancéreux : élimination et influence du cyclophosphamide et de ses principaux 684 métabolites sur le procédé, 2009.

A. Göbel, A. Thomsen, C. Mcardell, A. Joss, and W. Giger, Occurrence and Sorption Behavior of 686, 2005.

M. Sulfonamides and T. , Activated Sludge Treatment. Environ. Sci. Technol, vol.687, pp.3981-3989

S. Hann, . Ae-zs, A. Stefanka, A. Lenz, and . Stingeder, Novel separation method for highly sensitive 689 speciation of cancerostatic platinum compounds by HPLC-ICP-MS, Anal Bioanal Chem, vol.381, pp.690-405, 2005.

P. Hamon, Traitement des effluents d'un service d'oncologie par bioréacteur à membranes : 692 faisabilité d'acclimatation et gain apporté sur l'élimination de molécules médicamenteuses, Thèse, vol.693, 2013.

P. Hamon, M. Villain, and B. Marrot, Determination of sorption properties of micropollutants: What 695 is the most suitable activated sludge inhibition technique to preserve the biomass structure? 696, Chemical Engineering Journal, vol.242, pp.260-268, 2014.

I. Henriques, R. Holbrook, R. Kelly, and N. Love, The impact of floc size on respiration inhibition by 698 soluble toxicants-a comparative investigation, Water Research, vol.39, pp.2559-2568, 2005.

I. Henriques and N. Love, The role of extracellular polymeric substances in the toxicity response of 700 activated sludge bacteria to chemical toxins, Water Research, vol.41, pp.4177-4185, 2007.

M. Hörsing, A. Ledin, R. Grabic, J. Fick, M. Tysklind et al., Determination of 702 sorption of seventy-five pharmaceuticals in sewage sludge, Water Research, vol.45, pp.4470-4482, 2011.

A. Joss, E. Keller, A. Alder, A. Göbel, C. Mcardell et al., Removal of 704 pharmaceuticals and fragrances in biological wastewater treatment, Water Research, vol.39, pp.3139-3152, 2005.

A. Joss, S. Zabczynski, A. Göbel, B. Hoffmann, D. Löffler et al., Biological degradation of pharmaceuticals in municipal wastewater treatment: Proposing a 707 classification scheme, Water Research, vol.40, pp.1686-1696, 2006.

T. Kiffmeryer, H. Götze, M. Jursch, and U. Lüders, Trace enrichment, chromatographic separation 709 and biodegradation of cytostatic compounds in surface water, Fresenius J Anal Chem, vol.361, pp.185-191, 1998.

T. Kosjek, S. Perko, D. Zigon, and E. Heath, Fluorouracil in the environment: Analysis, occurrence, 711 degradation and transformation, Journal of Chromatography A, vol.1290, pp.66-72, 2013.

K. Kümmerer, T. Steger-hartmann, and M. Meyer, Biodegradability of the anti-tumour agent 713 ifosfamide and its occurrence in hospital effluents and communal sewage, Water Research, vol.31, issue.11, pp.2705-2710, 1997.

K. Kummerer and A. Al-ahmad, Biodegradability of the anti-tumor agents 5-fluorouracil, vol.716, 1997.

, impact of the chemical structure and synergistic toxicity with hospital 717 effluent, Acta Hydrochim. Hydrobiol, vol.25, issue.4, pp.166-172

K. Kummerer and E. Helmers, Hospital effluents as a source of platinum for the environment, 1997.

, Science of Total Environment, vol.193, pp.179-184

K. Kümmerer, The presence of pharmaceuticals in the environment due to human use -721 present knowledge and future challenges, Journal of Environmental Management, vol.90, issue.8, pp.2354-722, 2009.

S. Mahnik, K. Lenz, N. Weissenbacher, R. Mader, and M. Fuerhacker, Fate of 5-fluorouracil, vol.724, 2007.

, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated 725 sludge and treatment in a membrane-bio-reactor system, Chemosphere, vol.66, pp.30-37

T. Okuda, N. Yamashita, H. Tanaka, H. Matsukawa, and K. Tanabe, Development of extraction 727 method of pharmaceuticals and their occurrences found, 2009.

, Environment International, vol.35, pp.815-820

, Assessment of Technologies for the Removal of Pharmaceuticals and Personal Care 730, POSEIDON, 2006.

, Products in Sewage and Drinking Water Facilities to Improve the Indirect Potable Water Reuse

J. Radjenovic, M. Petrovic, and D. Barcelo, Fate and distribution of pharmaceuticals in wastewater 732 and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor 733 (MBR) treatment, Water Research, vol.43, pp.831-841, 2009.

R. Schwarzenbach, P. Gschwend, and D. Imboden, Environmental Organic Chemistry, p.735, 2003.
DOI : 10.1002/0471649643

. Interscience,

J. Seira, Rôle de la sorption et de la biodégradation dans l'élimination de micropolluants par 737 des procédés d'épuration biologique : application aux molécules anticancéreuses traitées par 738 bioréacteur à membrane, 2013.

J. Sipma, B. Osuna, N. Collado, H. Monclus, G. Ferrero et al., Comparison 740 of removal of pharmaceuticals in MBR and activated sludge systems, Desalination, vol.250, issue.2, pp.653-659, 2010.

J. Stevens-garmon, J. Drewes, S. Khan, J. Mcdonald, and E. Dickenson, Sorption of emerging trace 742 organic compounds onto wastewater sludge solids, Water Research, vol.45, pp.3417-3426, 2011.

S. Suarez, J. Lema, and F. Omil, Removal of pharmaceuticals and personal care products (PPCPs) 744 under nitrifying and denitrifying conditions, Water Research, vol.44, pp.3214-3224, 2010.

N. Tadkaew, M. Sivakumar, S. Khan, J. Mcdonald, and L. Nghiem, Effect of mixed liquor pH on the 746 removal of trace organic contaminants in a membrane bioreactor, Bioresource Technology, vol.101, pp.1494-1500, 2010.

N. Tadkaew, F. Hai, J. Mcdonald, S. Khan, and L. Nghiem, , p.749, 2011.

T. Ternes, N. Herrmann, M. Bonerz, T. Knacker, H. Siegrist et al., A rapid method to measure 750 the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage 751 sludge, Water Research, vol.38, pp.4075-4084, 2004.

T. Urase, C. Kagawa, and T. Kikuta, Factors affecting removal of pharmaceutical substances and 753 estrogens in membrane separation bioreactors, Desalination, vol.178, pp.107-113, 2005.

N. Vieno, T. Tuhkanen, and L. Kronberg, Elimination of pharmaceuticals in sewage treatment plants 755 in Finland, Water Research, vol.41, pp.1001-1012, 2007.

A. Wick, G. Fink, A. Joss, H. Siegrist, and T. Ternes, Fate of beta blockers and psycho-active drugs in 757 conventional wastewater treatment, Water Research, vol.43, pp.1060-1074, 2009.

S. Yang, C. Lin, A. Lin, and P. Hong, Sorption and biodegradation of sulfonamide antibiotics by 759 activated sludge: Experimental assessment using batch data obtained under aerobic conditions, 2011.

, Water Research, vol.45, pp.3389-3397

J. Yu, E. Bouwer, and M. Coelhan, Occurrence and biodegradability studies of selected 762 pharmaceuticals and personal care products in sewage effluent, Agricultural Water Management, vol.86, pp.763-72, 2006.

F. Zaviska, P. Drogui, A. Grasmick, A. Azais, and M. Héran, Nanofiltration membrane bioreactor for 765 removing pharmaceutical compounds, Journal of Membrane Science, vol.429, pp.121-129, 2013.